November 22, 2016 - By Marguerite Chambers · 0 Comments
The stock of ZYNEX INCORPORATED (OTCMKTS:ZYXI) registered a decrease of 70% in short interest. ZYXI’s total short interest was 300 shares in November as published by FINRA. Its down 70% from 1,000 shares, reported previously. The stock last traded at $0.32 per share. It is down 11.11% since April 20, 2016 and is downtrending. It has underperformed by 15.67% the S&P500.
Zynex, Inc. operates through the Electrotherapy and Pain Management Products segment. The company has a market cap of $11.79 million. The Firm conducts its business through its subsidiaries and the operating subsidiary is Zynex Medical, Inc. . It currently has negative earnings. The Company’s other subsidiaries include Zynex Monitoring Solutions, Inc. (ZMS) and Zynex Europe, ApS (ZEU).
Zynex, Inc., incorporated on December 31, 2001, operates through the Electrotherapy and Pain Management Products segment. The Firm conducts its business through its subsidiaries and the operating subsidiary is Zynex Medical, Inc. (ZMI). The Company’s other subsidiaries include Zynex Monitoring Solutions, Inc. (ZMS) and Zynex Europe, ApS (ZEU). ZMI designs, makes and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. ZMS is in the process of developing its blood volume monitoring product. ZEU intends to focus on sales and marketing its products within the international marketplace, upon receipt of necessary regulatory approvals. It markets and sells Zynex-manufactured products and distributes private labeled products. The Company’s products include NexWave, NeuroMove, InWave, Electrodes and Batteries.
More notable recent Zynex Inc. (OTCMKTS:ZYXI) news were published by: Bizjournals.com which released: “Zynex names new CFO; in talks with lender” on July 21, 2014, also Prnewswire.com with their article: “Zynex Hires Vice President of Finance” published on June 01, 2016, Businesswire.com published: “Zynex Acquires NeuroDyne Medical, Corp.” on March 12, 2012. More interesting news about Zynex Inc. (OTCMKTS:ZYXI) were released by: Themiddlemarket.com and their article: “Turnaround Tuesday: Struggling Medical Device Group Zynex Reaches Forbearance Deal” published on December 30, 2014 as well as Marketwired.com‘s news article titled: “Zynex Hires Michael Frabotta as VP of Sales” with publication date: October 16, 2014.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Marguerite Chambers